Analysis of demethylation drug 5-aza-2'-deoxycytidine in growth inhibition on bladder tumor cell
10.3760/cma.j.issn.1000-6702.2010.12.014
- VernacularTitle:5-氮-2'-脱氧胞苷对膀胱移行细胞癌的生长抑制作用
- Author:
Donghao SHANG
;
Yu DU
;
Lang FENG
;
Fengbo ZHANG
;
Qingjun LIU
;
Qiang SHAO
;
Wencheng Lü
;
Ye TIAN
- Publication Type:Journal Article
- Keywords:
Bladder neoplasms;
Demethylation;
Apoptosis;
Cell cycle
- From:
Chinese Journal of Urology
2010;31(12):831-834
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the growth suppressive effect of demethylation drug 5-aza-2'-deoxycytidine on bladder tumor cells. Methods The growth suppressive effect of DAC on 4 transitional cell carcinoma (TCC) cell lines was measured using the Cell Proliferation Reagent WST-1 assay.The effects of DAC on apoptosis induction and cell cycle arrest were analyzed by flow cytometric analysis. Caspase 3, 9 activities were analyzed by APOPCYTO Caspase Colorimetric Assay Kit and PCNA expression was also investigated by Western blot to clarify the mechanism of DAC against TCC. Results DAC inhibited the growth of all TCC cell lines tested in a dose-dependant manner, however,growth suppressive effect of DAC was independent of p53 status in TCC. DAC inhibited proliferation via inducing G2/M cell cycle arrest but not via inducing apoptosis. After treated with 0, 1 and 8 μmol/L DAC, cells of RTl 12 in G2/M phase was (36.3 ± 3.4) %, (46.2 ± 4.6) % and (56.5 ±6.2) %, TCCsup was (37.5 ± 3.8) %, (48.4 ±4.9) % and (60.1 ± 6.7) %, respectively. The expression of PCNA was decreased by DAC, but caspase3, 9 activities were not activated. Conclusion DAC could suppress the growth of TCC cells and might be a new strategy to treat bladder malignancy in the future.
